Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneity

Soomin Ahn, Hyun Jeong Kim, Eunyoung Kang, Eun Kyu Kim, Se Hyun Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park

Research output: Contribution to journalArticle

1 Scopus citations


Background: Multiplicity in breast cancer is common. Studies on multiple breast cancers have revealed high concordance in biomarker status among individual lesions. However, genomic differences among multiple lesions are not well-established. We aimed to investigate the potential genomic heterogeneity of multiple breast cancer. Methods: Twenty-one patients with radiologically and histologically evident multiple breast cancer with similar histology were included. Two lesions from each of the 21 patients were selected, and biomarker status was evaluated for each lesion. Capture-based targeted next-generation sequencing was performed using a cancer gene panel consisting of 170 genes. Results: We identified discordance in intrinsic subtype in 2 (10%) of the 21 patients. Pathogenic mutations were detected in 13 of the 21 patients, of whom 11 shared oncogenic variants in the two lesions. The remaining two patients yielded different mutation results for TP53, ATM, and PIK3CA. Difference in copy number alteration was observed in 7 (33%) of the 21 patients including ERBB2 (n = 2), FGFR1 (n = 2), and FGFR2 (n = 1) genes. Conclusion: Despite similar histologic features of the individual lesions, inter-lesional genomic difference was identified in more than one-third of the patients. Inter-lesional genomic heterogeneity needs to be considered when performing a genomic test in multiple breast cancers.

Original languageEnglish
Pages (from-to)697-704
Number of pages8
JournalBritish Journal of Cancer
Issue number5
StatePublished - 3 Mar 2020


Cite this